Abbott and Domantis Collaborate on Antibody Therapeutics
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)
Published: 2 Nov-2002
DOI: 10.3833/pdr.v2002.i30.974 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Abbott Laboratories signed a research and technology deal with Domantis Ltd, the second major deal of Domantis, to discover novel therapeutic products using Domantis’ domain antibody technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS